Rosaria Saletti | Chemical Biology | Best Researcher Award

Prof. Rosaria Saletti | Chemical Biology | Best Researcher Award

University of Catania | Italy

Prof. Rosaria Saletti is an Associate Professor of Organic Chemistry at the University of Catania, where she leads the Organic Mass Spectrometry Laboratory within the Department of Chemical Sciences. Graduating cum laude in Chemistry from the same university, Prof. Saletti has established herself as an expert in mass spectrometry, proteomics, and protein structural characterization. Her research is centered on the application of liquid chromatography-mass spectrometry (LC-MS) techniques for the analysis of proteins in various biological and food matrices. Her investigations have contributed significantly to the comparative proteomics of cereal kernels, characterization of milk proteins, and the study of VDAC (Voltage-Dependent Anion Channel) proteins. Notably, her work has helped clarify the molecular underpinnings of allergenicity in milk and advanced the understanding of disulfide bonding and post-translational modifications in mitochondrial proteins. Prof. Saletti has participated in numerous national and European research projects, including the Italian Human ProteomeNet (FIRB), SAMOTHRACE, and multiple PRIN projects (2006, 2022). She also contributes to international networks such as the European Network CHRX CT94-0425 and FAIR CT96-1170. Her industry collaborations include partnerships with SIFI SpA, Wyeth-Lederle, and Zoetis Manufacturing Italia. She is the author of over 100 publications indexed in Scopus, with 2,008 citations and an h-index of 29 (Scopus) and 2,650 citations with an h-index of 31 on Google Scholar. Prof. Saletti has also co-authored several book chapters on mass spectrometry and proteomics and holds editorial roles in journals like Foods and Current Clinical Pharmacology. Her international collaborations span renowned institutions such as the University of Mainz, Technical University of Denmark, and Rothamsted Research, UK. She is an active member of the Italian Chemical Society, Italian Proteomic Association, and European Proteomics Association. Prof. Saletti’s scientific rigor and contributions to analytical chemistry have made her a respected figure in proteomic research worldwide.

Profiles : Scopus | Orcid | Google scholar

Featured Publications

Pittalà, M. G. G., Cucina, A., Conti-Nibali, S., Cunsolo, V., Di Francesco, A., Saletti, R., & Reina, S. (2025). Structural characterization of intra- and intermolecular disulfide bonds in voltage-dependent anion channel 3 (VDAC3) protein from Rattus norvegicus by high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry, 1–16.

Di Francesco, A., Lanzoni, A., De Santis, M. A., Pittalà, M. G. G., Saletti, R., Cunsolo, V., & Righetti, P. G. (2025). In-depth shotgun proteomic characterization of chickpea (Cicer arietinum L.): A case study on the genotype Pascià grown using two water regimes. ACS Agricultural Science & Technology.

Pittalà, M. G. G., Reina, S., Cucina, A., Cunsolo, V., Guarino, F., Di Francesco, A., Saletti, R., & De Pinto, V. (2024). Intramolecular disulfide bridges in voltage-dependent anion channel 2 (VDAC2) protein from Rattus norvegicus revealed by high-resolution mass spectrometry. Journal of the American Society for Mass Spectrometry, 35(7), 1422–1433.

Di Francesco, A., De Santis, M. A., Lanzoni, A., Pittalà, M. G. G., Saletti, R., & Cunsolo, V. (2024). Mass spectrometry characterization of the SDS-PAGE protein profile of legumins and vicilins from chickpea seed. Foods, 13(6), 887.

Pittalà, M. G. G., Di Francesco, A., Cucina, A., Saletti, R., Zilberstein, G., Zilberstein, S., Cappellini, E., & Righetti, P. G. (2023). Count Dracula resurrected: Proteomic analysis of Vlad III the Impaler’s documents by EVA technology and mass spectrometry. Analytical Chemistry, 95(34), 12732–12744.

Punginelli, D., Catania, V., Vazzana, M., Mauro, M., Spinello, A., Barone, G., Cunsolo, V., Saletti, R., Di Francesco, A., Arizza, V., & Schillaci, D. (2022). A novel peptide with antifungal activity from red swamp crayfish Procambarus clarkii. Antibiotics, 11(12), 1792.

 

Ruoxuan Sun | Immunogenicity of Biotherapeutics | Best Researcher Award

Dr. Ruoxuan Sun | Immunogenicity of Biotherapeutics | Best Researcher Award

Takeda Pharmaceutical, United States

👨‍🎓Profiles

🎓 Early Academic Pursuits

He began their academic journey at Peking University, earning a Bachelor of Science (B.S.) in Pharmaceutical Sciences. Building upon this foundation, they pursued a Master of Science (M.S.) in the same discipline, demonstrating exceptional research capabilities. Continuing their academic excellence, Sun completed a Ph.D. in Pharmacy at Purdue University, where they delved into groundbreaking studies on immunotherapy and molecular biology.

💼 Professional Endeavors

Currently serving as a Research Senior Scientist at Takeda Pharmaceuticals in Cambridge, MA, He has been with the compan, ascending from Research Scientist I to their present senior role. Their responsibilities include: Anti-drug antibody (ADA) assay development for pre-clinical studies, Innovative wash-free platforms for bioanalysis using NanoBiT and fluorescence polarization strategies, Epitope profiling and immunogenicity risk assessment for novel therapeutic modalities, In silico and in vitro immunogenicity evaluations to assess and mitigate immunogenicity risks in large molecules and biotherapeutics.

🧪 Contributions and Research Focus

His research at Takeda and Purdue University spans a wide array of scientific domains: ADA assay innovations for therapeutic candidates such as antibodies, oligonucleotides, and lipid nanoparticles, Epitope mapping strategies to assess immunogenicity and optimize therapeutic candidates, Post-translational modification regulation of immune receptors, including the identification of FBXL20 as a regulator of 4-1BB, Cancer immunotherapy development, focusing on glycosylation targeting and immunotherapy combinations.

🌍 Impact and Influence

He has significantly influenced the fields of immunogenicity, bioanalysis, and cancer therapy through innovative research and industrial contributions. Their work has informed drug development processes, improved assay platforms, and expanded understanding of immunogenicity risks in preclinical and clinical studies. As a journal reviewer for esteemed publications like Redox Biology and Biomarker Research, Sun has contributed to the dissemination of high-quality research in their field.

📈 Academic Cites and Achievements

During their academic career, Sun authored pivotal publications focusing on the regulation of 4-1BB and cancer immunotherapy. Their impactful work has been recognized within the scientific community, leading to high citation metrics and collaborations with leading researchers.

🛠️ Technical Skills

He possesses a versatile skill set, blending expertise in immunogenicity assessment, molecular and cellular biology, biochemistry, and computational biology. Key proficiencies include: Development and validation of ADA and biomarker assays, Advanced protein purification and molecular cloning techniques, In silico modeling using platforms like Alphafold to predict immunogenicity.

📚 Teaching Experience

As a Graduate Teaching Assistant at Purdue University, He contributed to multiple academic disciplines: Organic Chemistry II Lab, Human Anatomy and Physiology Lab, Immunology, Integrated Pharmacotherapy. Their teaching fostered a new generation of pharmaceutical scientists, emphasizing practical skills and theoretical understanding.

🌟 Legacy and Future Contributions

His pioneering work in immunogenicity risk assessment and bioanalysis platform development has paved the way for safer and more effective therapeutic modalities. Looking ahead, Sun aims to further advance innovations in biotherapeutics, leveraging cutting-edge techniques and computational tools to address emerging challenges in drug development.

📖Notable Publications

  1. Corrigendum to “The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen”
    • Authors: Zheng, X., Chen, Y., Bai, M., Sun, R., Zeng, H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2021
  1. Corrigendum to ‘Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity’
    • Authors: Zheng, X., Ma, W., Sun, R., Xu, W., Zeng, H.
    • Journal: Redox Biology
    • Year: 2020
  1. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
    • Authors: Ye, S., Chen, X., Yao, Y., Shu, Y., Yin, H.
    • Journal: Scientific Reports
    • Year: 2019
  1. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen
    • Authors: Zheng, X., Chen, Y., Bai, M., Sun, R., Zeng, H.
    • Journal: Free Radical Biology and Medicine
    • Year: 2019
  1. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity
    • Authors: Zheng, X., Ma, W., Sun, R., Xu, W., Zeng, H.
    • Journal: Redox Biology
    • Year: 2018
  1. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells
    • Authors: Zheng, X., Xu, W., Sun, R., Dong, C., Zeng, H.
    • Journal: Chemico-Biological Interactions
    • Year: 2017
  1. Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress
    • Authors: Dong, C., Zhang, L., Sun, R., Zheng, X., Zeng, H.
    • Journal: Scientific Reports
    • Year: 2016
  1. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation
    • Authors: Zheng, X., Zhang, Y., Zhang, L., Sun, R., Zeng, H.
    • Journal: Biomedicine and Pharmacotherapy
    • Year: 2016